Logo image of CLBT

CELLEBRITE DI LTD (CLBT) Stock Fundamental Analysis

NASDAQ:CLBT - Nasdaq - IL0011794802 - Common Stock - Currency: USD

13.98  -0.27 (-1.89%)

After market: 13.98 0 (0%)

Fundamental Rating

5

Overall CLBT gets a fundamental rating of 5 out of 10. We evaluated CLBT against 281 industry peers in the Software industry. CLBT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CLBT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CLBT was profitable.
CLBT had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CLBT reported negative net income in multiple years.
Each year in the past 5 years CLBT had a positive operating cash flow.
CLBT Yearly Net Income VS EBIT VS OCF VS FCFCLBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

CLBT's Return On Assets of -27.36% is on the low side compared to the rest of the industry. CLBT is outperformed by 72.24% of its industry peers.
CLBT has a Return On Equity of -53.44%. This is in the lower half of the industry: CLBT underperforms 68.33% of its industry peers.
With an excellent Return On Invested Capital value of 11.22%, CLBT belongs to the best of the industry, outperforming 87.54% of the companies in the same industry.
CLBT had an Average Return On Invested Capital over the past 3 years of 7.06%. This is significantly below the industry average of 12.12%.
The last Return On Invested Capital (11.22%) for CLBT is above the 3 year average (7.06%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -27.36%
ROE -53.44%
ROIC 11.22%
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
CLBT Yearly ROA, ROE, ROICCLBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

CLBT's Operating Margin of 14.30% is amongst the best of the industry. CLBT outperforms 81.85% of its industry peers.
CLBT's Operating Margin has improved in the last couple of years.
CLBT's Gross Margin of 84.06% is amongst the best of the industry. CLBT outperforms 92.88% of its industry peers.
CLBT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.3%
PM (TTM) N/A
GM 84.06%
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
CLBT Yearly Profit, Operating, Gross MarginsCLBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CLBT is creating some value.
CLBT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CLBT has more shares outstanding
There is no outstanding debt for CLBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CLBT Yearly Shares OutstandingCLBT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CLBT Yearly Total Debt VS Total AssetsCLBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

CLBT has an Altman-Z score of 6.89. This indicates that CLBT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CLBT (6.89) is better than 75.09% of its industry peers.
There is no outstanding debt for CLBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.89
ROIC/WACC1.14
WACC9.88%
CLBT Yearly LT Debt VS Equity VS FCFCLBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

CLBT has a Current Ratio of 1.82. This is a normal value and indicates that CLBT is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.82, CLBT perfoms like the industry average, outperforming 56.58% of the companies in the same industry.
CLBT has a Quick Ratio of 1.79. This is a normal value and indicates that CLBT is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CLBT (1.79) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.79
CLBT Yearly Current Assets VS Current LiabilitesCLBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.91% over the past year.
The Revenue has grown by 22.05% in the past year. This is a very strong growth!
The Revenue has been growing by 18.47% on average over the past years. This is quite good.
EPS 1Y (TTM)27.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)22.05%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%20.06%

3.2 Future

The Earnings Per Share is expected to grow by 12.52% on average over the next years. This is quite good.
Based on estimates for the next years, CLBT will show a quite strong growth in Revenue. The Revenue will grow by 15.23% on average per year.
EPS Next Y11.44%
EPS Next 2Y10.76%
EPS Next 3Y14.31%
EPS Next 5Y12.52%
Revenue Next Year18.93%
Revenue Next 2Y18.12%
Revenue Next 3Y17.9%
Revenue Next 5Y15.23%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CLBT Yearly Revenue VS EstimatesCLBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
CLBT Yearly EPS VS EstimatesCLBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 31.77, which means the current valuation is very expensive for CLBT.
Compared to the rest of the industry, the Price/Earnings ratio of CLBT indicates a somewhat cheap valuation: CLBT is cheaper than 68.68% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.25. CLBT is around the same levels.
The Price/Forward Earnings ratio is 27.13, which means the current valuation is very expensive for CLBT.
Based on the Price/Forward Earnings ratio, CLBT is valued a bit cheaper than 67.62% of the companies in the same industry.
CLBT is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 36.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 31.77
Fwd PE 27.13
CLBT Price Earnings VS Forward Price EarningsCLBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLBT is valued a bit cheaper than 70.46% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CLBT is valued a bit cheaper than the industry average as 76.51% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 25.33
EV/EBITDA 38.08
CLBT Per share dataCLBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CLBT does not grow enough to justify the current Price/Earnings ratio.
CLBT's earnings are expected to grow with 14.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.78
PEG (5Y)N/A
EPS Next 2Y10.76%
EPS Next 3Y14.31%

0

5. Dividend

5.1 Amount

No dividends for CLBT!.
Industry RankSector Rank
Dividend Yield N/A

CELLEBRITE DI LTD

NASDAQ:CLBT (7/31/2025, 8:13:44 PM)

After market: 13.98 0 (0%)

13.98

-0.27 (-1.89%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)08-14 2025-08-14/bmo
Inst Owners41.93%
Inst Owner Change-0.03%
Ins Owners2.71%
Ins Owner ChangeN/A
Market Cap3.35B
Analysts84.29
Price Target25.5 (82.4%)
Short Float %2.88%
Short Ratio2.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.43%
Min EPS beat(2)0.93%
Max EPS beat(2)15.93%
EPS beat(4)4
Avg EPS beat(4)40.28%
Min EPS beat(4)0.93%
Max EPS beat(4)86.74%
EPS beat(8)8
Avg EPS beat(8)63.98%
EPS beat(12)10
Avg EPS beat(12)43.82%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.92%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)-0.26%
Revenue beat(4)2
Avg Revenue beat(4)0.31%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)2.78%
Revenue beat(8)6
Avg Revenue beat(8)1.51%
Revenue beat(12)7
Avg Revenue beat(12)-0.3%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-8.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.94%
EPS NY rev (1m)0%
EPS NY rev (3m)10.23%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-2.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.9%
Valuation
Industry RankSector Rank
PE 31.77
Fwd PE 27.13
P/S 7.99
P/FCF 25.33
P/OCF 23.41
P/B 9.21
P/tB 10.34
EV/EBITDA 38.08
EPS(TTM)0.44
EY3.15%
EPS(NY)0.52
Fwd EY3.69%
FCF(TTM)0.55
FCFY3.95%
OCF(TTM)0.6
OCFY4.27%
SpS1.75
BVpS1.52
TBVpS1.35
PEG (NY)2.78
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.36%
ROE -53.44%
ROCE 14.2%
ROIC 11.22%
ROICexc 375.49%
ROICexgc N/A
OM 14.3%
PM (TTM) N/A
GM 84.06%
FCFM 31.53%
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.94%
ROCE(5y)9.6%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
F-Score4
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 102.56%
Cap/Sales 2.58%
Interest Coverage 250
Cash Conversion 202.89%
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.79
Altman-Z 6.89
F-Score4
WACC9.88%
ROIC/WACC1.14
Cap/Depr(3y)92.67%
Cap/Depr(5y)99.76%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y11.44%
EPS Next 2Y10.76%
EPS Next 3Y14.31%
EPS Next 5Y12.52%
Revenue 1Y (TTM)22.05%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%20.06%
Revenue Next Year18.93%
Revenue Next 2Y18.12%
Revenue Next 3Y17.9%
Revenue Next 5Y15.23%
EBIT growth 1Y41.52%
EBIT growth 3Y30.51%
EBIT growth 5YN/A
EBIT Next Year30.19%
EBIT Next 3Y22.99%
EBIT Next 5Y18.58%
FCF growth 1Y269.63%
FCF growth 3Y63.25%
FCF growth 5Y65.07%
OCF growth 1Y228%
OCF growth 3Y54.2%
OCF growth 5Y52.3%